Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Arm, Open, Phase Ib Study Evaluating the Safety, Preliminary Efficacy of AL8326 in the Treatment of Non-Small Cell Lung Cancer

NCT06794957 is registered in ClinicalTrials.gov with Advenchen Laboratories, LLC as lead sponsor.

NCT NCT06794957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06794957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Arm, Open, Phase Ib Study Evaluating the Safety, Preliminary Efficacy of AL8326 in the Treatment of Non-Small Cell Lung Cancer
Lead sponsor
Advenchen Laboratories, LLC
Phase
Phase 1
Overall status
Active, not recruiting
Start date
May 19, 2022
Completion date
December 31, 2027
Enrollment
158 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer